A single-centre study looking at the effect of compression therapy in patients having foam sclerosant injection for varicose veins

Not Applicable

Completed

• Conditions: Varicose veins; Circulatory System; Varicose veins of lower extremities

• Registration Number: ISRCTN17719156
• Lead Sponsor: Imperial College London

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-04-20
• Study Completion: 2021-01-31
• Last Update Posted: 20 November 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 139

Inclusion Criteria

1. Adults over 18 years of age
2. Varicose veins suitable for foam sclerotherapy

Exclusion Criteria

1. Allergic to sclerosant
2. Current DVT
3. Arterial disease (ABPI<0.8)
4. Patients unable to wear compression stockings
5. Patient who are unwilling to participate
6. Inability or unwillingness to complete questionnaires
7. Inability to attend follow­up appointments

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain is measured using the visual analogue scale (VAS) at baseline and daily for the first 10 days post procedure.

Secondary Outcome Measures

Name	Time	Method
<br> 1. Quality of life is measured using EQ-5D, AVVQ and CIVIQ at baseline, 2 weeks and 6 months<br> 2. Clinical change is assessed using the VCSS at baseline, 2 weeks and 6 months<br> 3. Degree of phlebitis is assessed at 2 weeks and 6 months<br> 4. Degree of skin discolouration and matting is assessed at 2 weeks and 6 months<br> 5. Patient compliance with the intervention<br> 6. Time taken to return to work and normal activities<br> 7. Occlusion rates at 6 months<br> 8. Cost effectiveness of the intervention<br>